Limited Distribution Specialty Drugs Highlights SPT Week in Review

5. Medicare Could Save Billions with Additional Formulary Exclusions

G

reater use of substituting generic drugs could have a major impact on Medicare Part D spending. Read more.

4. Interrupting HIV Treatment in Clinical Trials Okay, NIH Study Says

Analytical treatment interruption may not cause long-term damage to patients with HIV. Read more.

3. Research Identifies Key Molecular Actions of Autoimmune, Inflammatory Diseases

An immunomodulatory cytokine interacts with its receptors differently than other cytokines. Read more.

2. Lawmakers Seek Transparency in 340B Program

Sen Bill Cassidy, MD (R-LA), proposes legislation that would require hospitals to pass 340B savings on to patients. Read more.

1. The Ins and Outs of Limited Distribution Specialty Drugs

Many factors influence whether a specialty pharmacy can gain access to limited distribution drug networks. Read more.